Coherus Oncology (CHRS) EBT Margin (2013 - 2026)
Coherus Oncology (CHRS) posted EBT Margin of -233.08% for Q2 2026, up 204.43 percentage points from -437.51% a year earlier and up 66.96 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) EBT Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Coherus Oncology was -316.37%, up 271.38 percentage points year-over-year; for FY2025, it was -434.23%, up 382.00 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of -462.75 percentage points (FY2020 to FY2025).
- In prior years, Coherus Oncology's EBT Margin was -816.23% in FY2024 (-723.60 pp), -92.62% in FY2023 (+45.62 pp), -138.24% in FY2022 (-50.33 pp) and -87.92% in FY2021 (-116.44 pp).
- The Q2 2026 figure stands as the highest quarterly EBT Margin since Q4 2023.
- On a year-over-year basis, EBT Margin has increased in each of the last six quarters, with an average year-over-year change of +292.48 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q1 2025, with a gain of 2324.09 percentage points; the weakest was Q1 2024, with a drop of 2714.36 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -300.04% (Q1 2026), -363.56% (Q4 2025) and -384.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.28 Bn | 1,194.89 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 653.62 Bn | 573.48 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 509.01 Bn | 477.02 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.31 Bn | 325.26 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 312.49 Bn | 285.73 Bn | - | - |
| 6 | Astrazeneca | 285.84 Bn | 259.73 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 248.19 Bn | 199.85 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.17 Bn | 183.27 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 166.64 Bn | 114.00 Bn | 12.56 Bn | 20.41% |
| 10 | Coherus Oncology | 116.82 Mn | -519.32 Mn | 10.07 Mn | -233.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -233.08% |
| Mar 31, 2026 | -300.04% |
| Dec 31, 2025 | -363.56% |
| Sep 30, 2025 | -384.73% |
| Jun 30, 2025 | -437.51% |
| Mar 31, 2025 | -623.74% |
| Dec 31, 2024 | -596.06% |
| Sep 30, 2024 | -786.50% |
| Jun 30, 2024 | -532.74% |
| Mar 31, 2024 | -2,947.83% |
| Dec 31, 2023 | -87.03% |
| Sep 30, 2023 | -53.67% |
| Jun 30, 2023 | -73.01% |
| Mar 31, 2023 | -233.47% |
| Dec 31, 2022 | -129.81% |
| Sep 30, 2022 | -190.76% |
| Jun 30, 2022 | -83.37% |
| Mar 31, 2022 | -159.83% |
| Dec 31, 2021 | -62.34% |
| Sep 30, 2021 | -46.70% |
API Access
Coherus Oncology EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();